Voronoi Selection for Cancer Drug Network Visualization in Mixed Reality
Researchers at the Englander Institute for Precision Medicine (EIPM) at Weill Cornell Medicine bring together basic science, medicine, DNA sequencing and big data to deliver the next generation of precision medicine; it is the most promising approach to tackle diseases like cancer, neurodegenerative diseases, and rare genetic conditions that have thus far eluded effective treatments. Their multidisciplinary team consists of physician-scientists, researchers, and bioinformaticians who are working together to identify the genetic alterations that drive the diseases and to form tailored, targeted treatments for every patient. This process is very data-intensive, involving integrating terabytes of information generated from genomic sequencing, heart rate, past clinical information, etc. To this end, EIPM developed Holo Graph, a HoloLens application that enables clinicians and researchers to visualize cancer drug networks in 3D, manipulate the structure and brainstorm with colleagues in real-time. This approach enables a new level of collaboration and analysis of data, not possible on a flat 2D screen
Light
Dark